The global fertility test market size was worth USD 390 Million in 2017 and is estimated to grow at a decent CAGR of 8.1% from 2018 to 2025. The market for Fertility Testing devices is accelerated to have the highest shares during the forecast period.
The fertility test is done to assess fertility, and several conditions are linked to it in both men and women. Infertility is a condition of a rational duration of unprotected sex without conception. Couples perform fertility tests to identify the main reason for infertility. The general practitioner or gynecologist first assesses the fertility test results to analyze the specific problem and recommends corrective treatment. Therefore, owing to the increasing demand for fertility testing devices, the global market is expected to increase in the near future.
MARKET DRIVERS:
The rise in fertility issues both in men and women due to change in lifestyle and food habits and awareness of the use of fertility monitors at home are majorly driving growth to the global fertility test market.
Some of the other factors boosting the growth of the global fertility test market are reducing the rate of fertility in men and women and the increasing prevalence of first-time pregnancy in women. Also, factors such as the continually increasing population of women affected with PCOS, rising awareness regarding the fertility tests among people in developed and developing countries, and the growing adoption rate of technologically advanced ovulation monitors are catalyzing the growth of the fertility test market.
The rise in demand for remote monitoring and self-testing in young women is lucratively setting up the growth opportunities for the market. The availability of some kits in online stores and their low cost are ascribed to bolster the market demand. Intensive focus on initiatives from the private and public organizations for developing novel techniques and devices for testing fertility rates in men and women are likely to offer growth opportunities for the key players in the global fertility test market during the forecast period.
The integration of smart technologies in healthcare is expected to provide growth opportunities for the fertility test market stakeholders during the projection period. The decreasing rate of fertility due to unhealthy lifestyles of the urban population and increasing account PCOS in women are creating lucrative opportunities in the worldwide fertility test market. The growing adoption rate of ovulation monitoring devices due to growing awareness among people regarding the benefits associated with the monitoring systems and the evolution of marketing strategies such as e-commerce sites and social media creates growth opportunities for the stakeholders in the fertility test market.
MARKET RESTRAINTS:
However, the significant factors that challenge the growth of the global fertility test market are inaccurate results by the ovulation prediction kits, and urine-based ovulation monitors are proven to be incorrect for the women affected by PCOS. Lack of awareness of these kits in rural areas is slowly dragging the demand of the market. Also, the lack of standardization and rapid changes in the economic strategies remain challenging factors in this market.
Impact of COVID-19 on the global fertility test market:
Fertility test market shares were preceding until the spread of COVID-19. The American Society of Reproductive System has issued a warning to anyone diagnosed with COVID 19 to avoid pregnancy. All the people undergoing fertility treatments like IUI, IVF, and others remain suspended unless and until further instructions. A person who was undergoing fertility treatment and having some reason to suspect COVID 19 symptoms need to contact the specialist immediately. During the lockdown period, all the necessary guidelines were imposed by the government. Patients who were about to undergo fertility tests were canceled and postponed.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Testing Device, Mode of Purchase, Application, End User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This research report on the global fertility test market segmented and sub-segmented based on testing device, mode of purchase, application, end-user, and region.
Fertility Test Market – By Testing Device:
Fertility Test Market – By Mode of Purchase:
Based on the testing devices, the ovulation predictor kits segment contributes a significant share of revenues to the global fertility test market. It is anticipated to continue its dominion during the outlook period. The factors that are boosting the growth of this segment are ovulation predictor kits are highly efficient and are sufficient to control costs, increasing prevalence of pregnancies in middle-aged women, and the growing demand for OPK kits.
Fertility Test Market – By Application:
Based on the application, the female fertility testing segment is leading the global fertility test market. It is anticipated to expand further during the estimated period due to the factors such as the availability of various testing procedures, the increasing prevalence of fertility issues in women, and the expensive nature of IVF testing techniques.
Fertility Test Market – By End User:
Based on end-users, in 2018, the home care settings segment dominated the market and is likely to display significant growth over the forecast period. It is due to the factors such as increasing demand for fertility tests due to the drop-in fertility rate in men and women, increasing demand, and availability of home and remote monitoring options in the market.
Fertility Test Market – By Region:
Regionally, North America holds the market with the highest revenue shares. The acceptance of advanced technology and the rise in pregnancy age women are fuelling the market's growth in this region. North America is expected to dominate the global fertility testing devices market due to several factors, including declining fertility rate due to increase in age of first pregnancy and high incidence of syndrome polycystic ovaries in women of this region and a growing awareness of the benefits provided by fertility awareness methods and ovulation monitors for a successful conception in women.
The Asia Pacific and Europe are next to North America is leading the highest shares of the global fertility test market with the rise in investments by the government for the development of fertility and ovulation monitors. The Asia-Pacific region is also expected to grow at a rapid rate in the market in the next period. The growth of this region can be attributed to several factors, such as the increase in the number of women with lifestyle disorders, the growing attention of national and international actors, the increase in costs of setting up ovulation and fertility monitors, and lowering the fertility rate.
In Europe, the average fertility rate is 1.8. The lowest fertility rates were recorded in southern Europe, Italy, Spain, and Portugal, ranging between 1.65 and 1.41. China's fertility rates are also falling. In China, the low fertility rate is a bigger problem than the aging population. According to the National Bureau of Statistics, last year, 18.14 million newborn babies were added to the Chinese population, a decrease of 645,200 year-on-year, and the birth rate fell from 13.42% in 2018 to 13.17% in 2019. Hence, declining fertility rates and increasing lifestyle disorders among women are expected to drive the market during the forecast period.
KEY MARKET PARTICIPANTS AND SHARE INSIGHTS:
Notable companies leading the global fertility test market profiled in this report are Advacare Pharma, AVA, Babystart, Biozhena, Church & Dwight (US), Fairhaven Health, Fertility Focus, Geratherm Medical, Hilin Life Products, Prestige Brands Holdings (A Part of Gregory Pharmaceutical Holdings) (US), Sensiia, Swiss Precision Diagnostics (SPD) (Switzerland), Taidoc, Uebe Medical and Valley Electronics.
New product launches are one of the major strategies that leading companies have adopted to maintain their domination.
In 2017, NFI Consumer Healthcare acquired the OCT pregnancy test kit, developed by Prestige Company.
In 2017, Swiss Precision Diagnostics released a Clearblue Connected Ovulation Test System for effective fertility testing.
In 2017, Fairhaven Health released a product called TempCue, and the product is used for measuring body temperature.
Related Reports
Feb 2020
